Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × olaparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 23 Breast Neoplasms 21 Fallopian Tube Neoplasms 13 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 8 Neoplasms 6 Endometrial Neoplasms 6 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Stomach Neoplasms 3 Lymphoma, Non-Hodgkin 3 Glioma 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Osteosarcoma 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Glioblastoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1

Interventions

durvalumab 3 Fulvestrant 3 Cisplatin 3 Carboplatin 3 ribociclib 2 pembrolizumab 2 palbociclib 2 abemaciclib 2 Pemetrexed 2 Letrozole 2 Anastrozole 2 trametinib 1 taletrectinib 1 sotorasib 1 selpercatinib 1 relatlimab 1 pralsetinib 1 exemestane 1 elacestrant 1 darolutamide 1 dabrafenib 1 ceralasertib 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Sunitinib 1 STX-478 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 RAD1901 1 Pregnancy Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡